A currently licensed rubella vaccine, HPV 77, produces arthralgia at high frequency in adult women. Thirty-nine susceptible adult women, ages 18 to 37 years, were inoculated with Cendehill, Benoit B, and Benoit C rubella vaccine strains and evaluated clinically and serologically. Benoit B produced rubellalike disease including polyarthralgia in five of seven women which, in one case, was of five months' duration. The postvaccination course of Benoit C vaccine was benign in all 11 subjects; only two of 28 Cendehill vaccinees had mild, transient arthralgia. Postvaccination hemagglutination-inhibition antibody to levels greater than 1:10 developed in all susceptible subjects. Benoit B vaccinees had the highest titers, Cendehill, intermediate values, while Benoit C titers were rather low. Cendehill and perhaps Benoit C strains appear to be immunogenic and clinically acceptable in adult women.
Halstead SB, Char DF, Diwan AR. Evaluation of Three Rubella Vaccines in Adult Women. JAMA. 1970;211(6):991–995. doi:10.1001/jama.1970.03170060055011
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: